申请人:MERCK SHARP & DOHME LTD.
公开号:EP0301729A1
公开(公告)日:1989-02-01
A class of novel oxadiazoles, substituted on one of the ring carbon atoms with a non-aromatic azacyclic or azabicyclic ring and on the other ring carbon atom with a substituent which is convertible in vivo to an amino group, are potent muscarinic agonists, and exhibit improved CNS penetrability and duration of action compared with the corresponding amino compounds. The compounds are therefore useful in the treatment of neurological and mental illnesses.
一类新型噁二唑的一个环碳原子被非芳族氮杂环或氮杂环取代,另一个环碳原子被可在体内转化为氨基的取代基取代,它们是强效的毒蕈碱激动剂,与相应的氨基化合物相比,具有更好的中枢神经系统穿透性和作用持续时间。因此,这些化合物可用于治疗神经和精神疾病。